A selective and potent 5-HT3
= 2.9 nM).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The effects of orally administered Y-25130, a selective serotonin3 receptor antagonist on chemotherapeutic agent-induced emesis.
Haga et al.
The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
Fukuda et al.
Antagonistic activity of Y-25130 on 5-HT3 receptors.
Sato et al.
The citations listed below are publications that use Tocris products. Selected citations for Y-25130 hydrochloride include:
Showing Results 1 - 1 of 1